Transgenders: a debate with the UMCG Genderteam and a patient

Supervisors: Tim R. Middelberg MD PhD, Tallechien M.T. Tempelman MD, M. van den Berg MD, Marga Tjallingii MSc

Department: Genderteam UMCG (gynaecology and plastic surgery).

Transgender people experience a mismatch between their gender identity or gender expression and their assigned sex. Transgender is an umbrella term, because in addition to including trans men and trans women (whose binary gender identity is the opposite of their assigned sex), it may also include gender queer people (whose identities are not exclusively masculine or feminine, for example: bigender, pangender, genderfluid, or agender).

Since the late 70’s the University Medical Center of Groningen (UMCG) in the Netherlands offers a treatment program for transgenders, according to the professional standards of the World Professional Association of Transgender Health (WPATH). Once patients have been diagnosed with genderdysphoria by the psychiatrist, the ‘real life phase’ starts, including living their gender identity and cross sex hormone therapy. When the ‘real-life phase’ has been followed through with success, one can apply for sex reassignment surgery. After these operations, lifelong continuation of cross sex hormone therapy is needed to maintain secondary sex characteristics of the desired gender.

What does the transition contain and causes both physically, mentally and socially and how can we guide the patients in this process?
During this workshop you will be able to ask questions to a member of the UMCG Genderteam and a transgender patient.